Novartis Ag (NVS) Intangibles (2009 - 2026)
Novartis Ag (NVS) reported Intangibles of $42.07 billion for Q2 2026, up 43.9% from $29.24 billion a year earlier and up 4.6% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag posted Intangibles of $29.41 billion, up 9.3% from FY2024.
- Intangibles has a five-year compound annual growth rate of -4.4% (FY2020 to FY2025).
- By year, Intangibles came in at $26.92 billion in FY2024 (+0.1%), $26.88 billion in FY2023 (-15.1%), $31.64 billion in FY2022 (-7.4%) and $34.18 billion in FY2021 (-7.1%).
- The Q2 2026 figure ranks as the highest quarterly Intangibles in data going back to Q1 2009.
- Year over year, Intangibles has now increased in each of the last eight quarters, with growth averaging 14.9% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was Q1 2022 (growth of 632.5%); the low point was Q3 2023 (a decline of 17.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $40.21 billion (Q1 2026), $29.41 billion (Q4 2025) and $29.04 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 412.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.07 Bn |
| Mar 31, 2026 | 40.21 Bn |
| Dec 31, 2025 | 29.41 Bn |
| Sep 30, 2025 | 29.04 Bn |
| Jun 30, 2025 | 29.24 Bn |
| Mar 31, 2025 | 27.48 Bn |
| Dec 31, 2024 | 26.92 Bn |
| Sep 30, 2024 | 27.90 Bn |
| Jun 30, 2024 | 27.78 Bn |
| Mar 31, 2024 | 26.27 Bn |
| Dec 31, 2023 | 26.88 Bn |
| Sep 30, 2023 | 26.42 Bn |
| Jun 30, 2023 | 28.00 Bn |
| Mar 31, 2023 | 30.45 Bn |
| Dec 31, 2022 | 31.64 Bn |
| Sep 30, 2022 | 31.89 Bn |
| Jun 30, 2022 | 33.37 Bn |
| Mar 31, 2022 | 34.85 Bn |
| Dec 31, 2021 | 34.18 Bn |
| Sep 30, 2021 | 33.95 Bn |
API Access
Novartis Ag Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();